These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 6387926
21. Early prediction of chronic lung disease by pulmonary function testing. Goldman SL, Gerhardt T, Sonni R, Feller R, Hehre D, Tapia JL, Bancalari E. J Pediatr; 1983 Apr; 102(4):613-7. PubMed ID: 6834201 [No Abstract] [Full Text] [Related]
22. The first expiration: role of pulmonary surfactant. Chernick V. Semin Perinatol; 1977 Oct; 1(4):351-5. PubMed ID: 382368 [No Abstract] [Full Text] [Related]
23. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease]. Leroy JL. J Gynecol Obstet Biol Reprod (Paris); 1982 Oct; 11(1):152-7. PubMed ID: 6896522 [No Abstract] [Full Text] [Related]
25. Respiratory distress syndrome in the tiny baby. Fawcett WA, Gluck L. Clin Perinatol; 1977 Sep; 4(2):411-23. PubMed ID: 332436 [No Abstract] [Full Text] [Related]
26. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants]. Saule H. Med Klin; 1975 Mar 07; 70(10):409-15. PubMed ID: 1091827 [No Abstract] [Full Text] [Related]
27. The artificially ventilated preterm rabbit neonate as experimental model of hyaline membrane disease. Nilsson R. Acta Anaesthesiol Scand; 1982 Apr 07; 26(2):89-103. PubMed ID: 7048842 [Abstract] [Full Text] [Related]
28. Perfluorochemical liquid ventilation: from the animal laboratory to the intensive care unit. Degraeuwe PL, Vos GD, Blanco CE. Int J Artif Organs; 1995 Oct 07; 18(10):674-83. PubMed ID: 8647601 [Abstract] [Full Text] [Related]
29. [Results of treatment of hyaline membrane disease of the newborn infant with artificial respiration]. De Bruijne JI, Deen L, Koppe JG. Maandschr Kindergeneeskd; 1969 Dec 07; 37(7):252-60. PubMed ID: 5361968 [No Abstract] [Full Text] [Related]
30. [Results of artificial respiration therapy in hyaline membrane disease of the premature infant]. de Bruijne JI, Deen L, Koppe JG. Ned Tijdschr Verloskd Gynaecol; 1969 Oct 07; 69(5):392-400. PubMed ID: 5345138 [No Abstract] [Full Text] [Related]
31. [Respiratory pathology of the premature infant]. Menguy C. Soins Gynecol Obstet Pueric Pediatr; 1969 Oct 07; (139-140):22-7. PubMed ID: 1308631 [No Abstract] [Full Text] [Related]
32. [Improvement of pulmonary blood oxygenation in newborn infants at the early stage of hyaline membrane disease by certain adjustments of artificial ventilation]. Huault G. Arch Fr Pediatr; 1972 Oct 07; 29(6):671-2. PubMed ID: 5078370 [No Abstract] [Full Text] [Related]
33. Changes of venous admixture with inspired oxygen in hyaline membrane disease and foetal aspiration pneumonia. Corbet AJ, Burnard ED. Aust Paediatr J; 1973 Feb 07; 9(1):25-30. PubMed ID: 4736055 [No Abstract] [Full Text] [Related]
34. The lung of the premature infant: pathophysiology of disease and newer therapies. Robbins C, Green R, Lasker M, Wiseman G, Holzman IR. Mt Sinai J Med; 1994 Oct 07; 61(5):416-23. PubMed ID: 7799978 [No Abstract] [Full Text] [Related]
35. Patient-triggered ventilation in the newborn. Mehta A, Wright BM, Callan K, Stacey TE. Lancet; 1986 Jul 05; 2(8497):17-9. PubMed ID: 2873318 [No Abstract] [Full Text] [Related]
36. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study]. Sánchez-Mendiola M, Martínez-Natera OC, Herrera-Maldonado N, Ortega-Arroyo J. Gac Med Mex; 2005 Jul 05; 141(4):267-71. PubMed ID: 16164120 [Abstract] [Full Text] [Related]
37. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs]. Puchkov GF, Iazvinskiĭ II. Sov Med; 1975 Aug 05; (8):62. PubMed ID: 1105810 [No Abstract] [Full Text] [Related]